Spots Global Cancer Trial Database for Outcomes of TAMIS-Total Mesorectal Excision Versus Transanal Loco-regional Excision for T2 Low Rectal Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Outcomes of TAMIS-Total Mesorectal Excision Versus Transanal Loco-regional Excision for T2 Low Rectal Cancer
Official Title: Outcomes Comparison of TAMIS-TME Versus Transanal Minimally Invasive Locoregional Resection for T2 Low Rectal Cancer: an Open Label Study
Study ID: NCT02488577
Conditions
Study Description
Brief Summary: Cases with stage T2 N0 low rectal cancer will undergo either Transanal minimally invasive total mesorectal excision or transanal minimally invasive locoregional resection.
Detailed Description:
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Contact Details
Name: Sherif Kotb, M.D., PhD.
Affiliation: Professor of surgical oncology Mansoura university
Role: STUDY_DIRECTOR
Name: Osama Eldamshety, PhD
Affiliation: surgical oncology Mansoura university
Role: PRINCIPAL_INVESTIGATOR
Name: Adel Fathi, M.D.
Affiliation: surgical oncology Mansoura university
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
